These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34547922)

  • 21. Performance of prostate multiparametric MRI for prediction of prostate cancer extra-prostatic extension according to NCCN risk categories: implication for surgical planning.
    Falagario UG; Jambor I; Ratnani P; Martini A; Treacy PJ; Wajswol E; Lantz A; Papastefanou G; Weil R; Phillip D; Lewis S; Haines K; Cormio L; Carrieri G; Kyprianou N; Wiklund P; Tewari AK
    Minerva Urol Nefrol; 2020 Dec; 72(6):746-754. PubMed ID: 32182231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association between perineural invasion in mpMRI-targeted and/or systematic prostate biopsy and adverse pathological outcomes in robot-assisted radical prostatectomy.
    Karsiyakali N; Bulent Ozgen M; Ozveren B; Akbal C; Dincer A; Durak H; Turkeri L
    Actas Urol Esp (Engl Ed); 2022; 46(6):377-384. PubMed ID: 35260369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic accuracy of multiparametric magnetic resonance imaging in detecting extracapsular extension in intermediate and high - risk prostate cancer.
    Dominguez C; Plata M; Cataño JG; Palau M; Aguirre D; Narvaez J; Trujillo S; Gómez F; Trujillo CG; Caicedo JI; Medina C
    Int Braz J Urol; 2018; 44(4):688-696. PubMed ID: 29570254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association Between Oncotype DX Genomic Prostate Score and Adverse Tumor Pathology After Radical Prostatectomy.
    Covas Moschovas M; Chew C; Bhat S; Sandri M; Rogers T; Dell'Oglio P; Roof S; Reddy S; Sighinolfi MC; Rocco B; Patel V
    Eur Urol Focus; 2022 Mar; 8(2):418-424. PubMed ID: 33757735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Less qualitative multiparametric magnetic resonance imaging in prostate cancer can underestimate extraprostatic extension in higher grade tumors.
    Schmit S; Allu S; Tanzer JR; Ortiz R; Pareek G; Hyams E
    Int Braz J Urol; 2024; 50(1):37-45. PubMed ID: 38166221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of biparametric versus multiparametric prostate MRI for the detection of extracapsular extension and seminal vesicle invasion in biopsy naïve patients.
    Caglic I; Sushentsev N; Shah N; Warren AY; Lamb BW; Barrett T
    Eur J Radiol; 2021 Aug; 141():109804. PubMed ID: 34062473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between the extent of extraprostatic extension and survival following radical prostatectomy.
    Jeong BC; Chalfin HJ; Lee SB; Feng Z; Epstein JI; Trock BJ; Partin AW; Humphreys E; Walsh PC; Han M
    Eur Urol; 2015 Feb; 67(2):342-6. PubMed ID: 24968968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. External Validation of a Multiparametric Magnetic Resonance Imaging-based Nomogram for the Prediction of Extracapsular Extension and Seminal Vesicle Invasion in Prostate Cancer Patients Undergoing Radical Prostatectomy.
    Diamand R; Ploussard G; Roumiguié M; Oderda M; Benamran D; Fiard G; Quackels T; Assenmacher G; Simone G; Van Damme J; Malavaud B; Iselin C; Descotes JL; Roche JB; Peltier A; Roumeguère T; Albisinni S
    Eur Urol; 2021 Feb; 79(2):180-185. PubMed ID: 33023770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histological findings of totally embedded robot assisted laparoscopic radical prostatectomy (RALP) specimens in 1197 men with a negative (low risk) preoperative multiparametric magnetic resonance imaging (mpMRI) prostate lobe and clinical implications.
    Yaxley WJ; Nouhaud FX; Raveenthiran S; Franklin A; Donato P; Coughlin G; Kua B; Gianduzzo T; Wong D; Parkinson R; Brown N; Samaratunga H; Delahunt B; Egevad L; Roberts M; Yaxley JW
    Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):398-405. PubMed ID: 32999464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combining prostate health index and multiparametric magnetic resonance imaging may better predict extraprostatic extension after radical prostatectomy.
    Huang YP; Lin TP; Shen SH; Cheng WM; Huang TH; Huang IS; Fan YH; Lin CC; Huang EYH; Chung HJ; Lu SH; Chang YH; Lin ATL; Huang WJ
    J Chin Med Assoc; 2023 Jan; 86(1):52-56. PubMed ID: 36346752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Grading System for the Assessment of Risk of Extraprostatic Extension of Prostate Cancer at Multiparametric MRI.
    Mehralivand S; Shih JH; Harmon S; Smith C; Bloom J; Czarniecki M; Gold S; Hale G; Rayn K; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
    Radiology; 2019 Mar; 290(3):709-719. PubMed ID: 30667329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy: is adjuvant radiation warranted?
    Simon RM; Howard LE; Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Cooperberg MR; Vidal AC
    BJU Int; 2016 Jun; 117(6):897-903. PubMed ID: 26010251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: a nationwide population-based study.
    Kristiansen A; Drevin L; Delahunt B; Samaratunga H; Robinson D; Franck Lissbrant I; Stattin P; Egevad L
    Pathology; 2017 Dec; 49(7):715-720. PubMed ID: 29037803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Focused Submission of Tissue for Radical Prostatectomy Following Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion-Targeted Biopsy.
    Fasciano D; Eich ML; Del Carmen Rodriguez Pena M; Rais-Bahrami S; Gordetsky J
    Int J Surg Pathol; 2020 Feb; 28(1):44-50. PubMed ID: 31342804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Impact of Magnetic Resonance Imaging on Prediction of Extraprostatic Extension and Prostatectomy Outcome in Patients with Low-, Intermediate- and High-Risk Prostate Cancer: Try to Find a Standard.
    Radtke JP; Hadaschik BA; Wolf MB; Freitag MT; Schwab C; Alt C; Roth W; Duensing S; Pahernik SA; Roethke MC; Schlemmer HP; Hohenfellner M; Teber D
    J Endourol; 2015 Dec; 29(12):1396-405. PubMed ID: 26154571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics and oncological outcomes in negative multiparametric MRI patients undergoing robot-assisted radical prostatectomy.
    Wagaskar VG; Ratnani P; Levy M; Moody K; Garcia M; Pedraza AM; Parekh S; Pandav K; Shukla B; Sobotka S; Haines K; Wiklund P; Tewari A
    Prostate; 2021 Aug; 81(11):772-777. PubMed ID: 34057211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of nerve-sparing radical prostatectomy for clinical stage B2 prostate cancer.
    Bigg SW; Kavoussi LR; Catalona WJ
    J Urol; 1990 Dec; 144(6):1420-4. PubMed ID: 1700156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative multiparametric MRI does not lower positive surgical margin rate in a large series of patients undergoing robot-assisted radical prostatectomy.
    Gietelink L; Jansen BHE; Oprea-Lager DE; Nieuwenhuijzen JA; Vis AN
    J Robot Surg; 2022 Apr; 16(2):273-278. PubMed ID: 33811618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unilateral Pelvic Lymph Node Dissection in Prostate Cancer Patients Diagnosed in the Era of Magnetic Resonance Imaging-targeted Biopsy: A Study That Challenges the Dogma.
    Martini A; Wever L; Soeterik TFW; Rakauskas A; Fankhauser CD; Grogg JB; Checcucci E; Amparore D; Haiquel L; Rodriguez-Sanchez L; Ploussard G; Qiang P; Affentranger A; Marquis A; Marra G; Ettala O; Zattoni F; Falagario UG; De Angelis M; Kesch C; Apfelbeck M; Al-Hammouri T; Kretschmer A; Kasivisvanathan V; Preisser F; Lefebvre E; Olivier J; Radtke JP; Briganti A; Montorsi F; Carrieri G; Moro FD; Boström P; Jambor I; Gontero P; Chiu PK; John H; Macek P; Porpiglia F; Hermanns T; van den Bergh RCN; van Basten JA; Gandaglia G; Valerio M
    J Urol; 2023 Jul; 210(1):117-127. PubMed ID: 37052480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRI lesion size is more important than the number of positive biopsy cores in predicting adverse features and recurrence after radical prostatectomy: implications for active surveillance criteria in intermediate-risk patients.
    Baboudjian M; Uleri A; Beauval JB; Touzani A; Diamand R; Roche JB; Lacetera V; Lechevallier E; Roumeguère T; Simone G; Benamran D; Fourcade A; Fiard G; Peltier A; Ploussard G
    Prostate Cancer Prostatic Dis; 2024 Jun; 27(2):318-322. PubMed ID: 37452146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.